Tebipenem as an oral alternative for the treatment of typhoid caused by XDRSalmonellaTyphi | Zendy

Elli Mylona | Zendy; Phat Voong Vinh | Zendy; Sonia Qureshi | Zendy; Abhilasha Karkey | Zendy; Sabina Dongol | Zendy; Tuyen Ha Thanh | Zendy; Judd L. Walson | Zendy; Lluís Ballell | Zendy; Elena Fernández Álvaro | Zendy; Farah Naz Qamar | Zendy; Stephen Baker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tebipenem as an oral alternative for the treatment of typhoid caused by XDRSalmonellaTyphi

Author(s) -

Elli Mylona,

Phat Voong Vinh,

Sonia Qureshi,

Abhilasha Karkey,

Sabina Dongol,

Tuyen Ha Thanh,

Judd L. Walson,

Lluís Ballell,

Elena Fernández Álvaro,

Farah Naz Qamar,

Stephen Baker

Publication year - 2021

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkab326

Subject(s) - salmonella typhi , medicine , salmonella , typhoid fever , antimicrobial , microbiology and biotechnology , shigella , virology , biology , bacteria , escherichia coli , biochemistry , genetics , gene

Antimicrobial therapy is essential for the treatment of enteric fever, the infection caused by Salmonella serovars Typhi and Paratyphi A. However, an increase in resistance to key antimicrobials and the emergence of MDR and XDR in Salmonella Typhi poses a major threat for efficacious outpatient treatments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research